Acucela Inc.

Roswell, GA Acucela Inc. DBA Kubota Vision Inc.

UEI
FNW1T78KSWC1
CAGE
46NV0
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Foreign Owned
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
345 Buckingham Forest Ct, Roswell, GA 30075, USA
Website
kubotavision.com
Founded
2002
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
A phase 3 study of emixustat hydrochloride for stargardt disease IND 101,084 (02/11/2019) R01FD006849 FDA Office of Acquisition and Grant Services $3,268,917
Identifying cytoprotectants for photoreceptors and RPE cells to treat dry AMD R43EY018266 National Institutes of Health $99,295
In vitro assay to assess chemical toxicity in retinal primary cell cultures R43ES015667 National Institutes of Health $100,000

Quick answers

Is Acucela Inc. registered in SAM.gov?

Yes. Acucela Inc.'s SAM.gov registration is active through September 30, 2027.

What is Acucela Inc.'s most recent federal award?

Acucela Inc.'s most recent federal grant award is A phase 3 study of emixustat hydrochloride for stargardt disease IND 101,084 (02/11/2019) (R01FD006849), from FDA Office of Acquisition and Grant Services, on August 15, 2020.

On GovTribe

See Acucela Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login